Freund R, Dawe C J, Carroll J P, Benjamin T L
Department of Pathology, Harvard Medical School, Boston, MA 02115.
Am J Pathol. 1992 Dec;141(6):1409-25.
Alterations in the tumor-inducing ability of a polyoma virus mutant encoding a partially defective middle T oncogene have been investigated. The mutant middle T associates with and activates the tyrosine protein kinase pp60c-src normally but does not promote binding of a second enzyme, phosphatidyl-inositol 3-kinase. Compared with the wild type virus, this mutant shows an altered and reduced ability to induce tumors after inoculation into newborn mice, as judged by the following criteria: lower frequency of tumors, reduced morbidity and increased survival times of host mice, changes in the spectrum of tumor types, and altered morphologic properties of tumors at several target organ sites. These results indicate an important role of changes in 3-phosphoinositide metabolism in induction of a variety of tumors in this experimental system.
对编码部分缺陷型中间T癌基因的多瘤病毒突变体的致瘤能力改变进行了研究。该突变体中间T蛋白能正常地与酪氨酸蛋白激酶pp60c-src结合并激活它,但不能促进第二种酶磷脂酰肌醇3-激酶的结合。与野生型病毒相比,将这种突变体接种到新生小鼠后,根据以下标准判断,其致瘤能力发生改变且降低:肿瘤发生率降低、宿主小鼠发病率降低和存活时间延长、肿瘤类型谱改变以及多个靶器官部位肿瘤的形态学特性改变。这些结果表明,在该实验系统中,3-磷酸肌醇代谢变化在多种肿瘤的诱导中起重要作用。